Why did One Medical buy Iora for $2.1 billion?
One Medical’s $2.1 billion buy up of Iora came as a bit of a shock this week. It’s not the first acquisition I would have expected from One Medical, although in hindsight I can totally understand the rationale.
To get a perspective on the news, I reached out to Malay Gandhi for an authentic take. If you don’t already know him personally, Malay is an OG digital health strategist and thinker. He’s formerly of Evidation and Rock Health - and is now with Benchling.
So thanks Malay!
About the author
Christina Farr
Christina Farr is a healthcare writer and investor. Formerly at CNBC and Reuters, she covers digital health, startups, and policy, blending reporting with analysis and investing perspective to help leaders navigate healthcare’s evolving landscape.
New York City